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Background: The burden of chronic kidney disease (CKD) will rise in parallel with the growing prevalence of
type two diabetes mellitus in South Asia but is understudied. Using a cross-sectional survey of adults living in a
middle-income neighborhood of Dhaka, Bangladesh, we tested the hypothesis that the prevalence of CKD in this
group would approach that of the U.S. and would be strongly associated with insulin resistance.
Methods: We enrolled 402 eligible adults (>30 years old) after performing a multi-stage random selection procedure.
We administered a questionnaire, and collected fasting serum samples and urine samples. We used the Chronic Kidney
Disease Epidemiology Collaboration (CKD-EPI) equation to estimate glomerular filtration rate, and sex-specific cut
offs for albuminuria: > 1.9 mg/mmol (17 mg/g) for men, and >2.8 mg/mmol (25 mg/g) for women. We assessed
health-related quality of life using the Medical Outcomes Study Short Form-12 (SF-12).
Results: A total of 357 (89%) participants with serum samples comprised the analytic cohort. Mean age of was
49.5 (± 12.7) years. Chronic kidney disease was evident in 94 (26%). Of the participants with CKD, 58 (62%) had
albuminuria only. A participant with insulin resistance had a 3.6-fold increase in odds of CKD (95% confidence
interval 2.1 to 6.4). Participants with stage three or more advanced CKD reported a decrement in the Physical
Health Composite score of the SF-12, compared with participants without CKD.
Conclusion: We found an alarmingly high prevalence of CKD—particularly CKD associated with insulin
resistance—in middle-income, urban Bangladeshis.
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Until recently, most experts presumed that glomeru-
lonephritis or interstitial nephritis were predominant
reasons for chronic kidney disease (CKD) in low-and
middle-income regions including South Asia [1]. But
with an aging population and rapid urbanization, obesity
and type two diabetes mellitus (T2DM) afflicts a grow-
ing proportion of adults [2,3]. In fact, T2DM already
affects nearly 10% of the South Asian population, a bur-
den that approaches that of the U.S., and one that will* Correspondence: sanand2@stanford.edu
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reproduction in any medium, provided the orlikely rise at a much faster rate over the next two de-
cades [4]. The prevalence of CKD, particularly CKD
related to insulin resistance, will rise in parallel but has
been understudied.
Few [5-7] studies have examined the prevalence of
CKD in South Asia: most have not used a standard def-
inition of CKD, nor have they assessed albuminuria. In
addition, the populations surveyed have not been those
at highest risk (i.e., middle income, urban adults who
have greater access to energy-dense processed or fast
foods). Urban adults have also adopted a sedentary life-
style, owing in part to the changing nature of their
employment, crowding in residential areas, and the ubi-
quity of televisions [8].Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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high-risk group, we performed a cross-sectional multi-
stage random sampled survey of adults living in a
middle-income neighborhood in Dhaka, Bangladesh.
We hypothesized that the prevalence of CKD would ap-
proach that of the U.S., and that a majority of participants
with CKD would possess features of insulin resistance.
Methods
We performed a cross-sectional survey of 402 adult re-
sidents of Dhaka to examine the prevalence of obesity
and chronic diseases, including T2DM, hypertension,
and CKD. This multistage cluster random sampled
survey consisted of: 1. a patient questionnaire, 2. an-
thropometric measurements, and 3. fasting serum sample
and urine collection. The Institutional Review Board at
Stanford University and the Ethical Review Committee
at International Center for Diarrheal Diseases Research,
Bangladesh (ICDDR,B) approved the study.
Survey design
We obtained a detailed map of Mohammedpur, an urban
residential area organized in the 1950s within Dhaka
with a population of about 450,000 people living in
100,000 households [9]. Of the six blocks that comprise
the district, we randomly selected three. We then assigned
a study identification number to all of the buildings in the
three blocks, and used random sample generator software
(SPSS, Chicago, IL) to create a list of 500 buildings. We
selected extra buildings to ensure enrollment of one per-
son per building. Most buildings in Mohammedpur are
apartment complexes. On arrival at a selected building,
the survey team—made up of a research assistant, study
nurse and study supervisor—counted the total number of
households, and utilized a random number generator to
select a single household. If the household members
declined to participate or there was non-response, the sur-
vey team randomly selected another household within the
same building.
Eligible participants were at least 30 years old; if there
were more than one eligible participant in the selected
household, we randomly selected one from all eligible
participants using the same random number generator.
We targeted equal enrollment of men and women in the
30 to 50 and > 50 year age category (i.e., 100 individuals in
each category). We enrolled participants until the quota
for any given combination was reached, after which partic-
ipants were enrolled only into the remaining strata.
Data collection
After obtaining informed consent, research assistants
administered a patient questionnaire in Bangla. Using
a structured questionnaire, we obtained data on: so-
cioeconomic status including education and occupation,tobacco use, self-reported personal and family history of
chronic diseases, diet and physical activity, and family
planning. We administered the Medical Outcomes Study
Short-Form-12 version two questionnaire (SF-12) to assess
health related quality of life (HRQoL). At the completion
of the patient questionnaire, the research assistant made
an appointment for a second visit (within one week) to
obtain a urine specimen, fasting serum sample, and
anthropometric measurements.
A study nurse measured height, weight, and waist and
hip circumference on all participants using standardized
procedures [10]. The nurse also obtained two blood pres-
sure readings using a manual sphygmomanometer after
the participant had remained in a seated position for five
minutes with his or her arm resting on the chair. The
nurse used standard phlebotomy procedures to obtain a
fasting serum sample and a urine specimen.
Laboratory analyses
We transported serum and urine samples to the ICDDR,
B central laboratory within one hour of collection. We
processed all samples for serum creatinine, hemoglobin
A1c, and fasting glucose. Due to budgetary limitations,
we performed more expensive tests—urine albumin and
creatinine, and serum lipids and triglycerides—in a select
group of participants. This group (n = 341) fit at least one
criteria for metabolic syndrome, had urine dipstick
positive for proteinuria, or had risk factors for CKD
(i.e., self-reported personal or family history of diabetes,
hypertension, or CKD, or self-reported personal history
of auto-immune disease, kidney stones, or birth weight
below 2.5 kg) [11].
Urine albumin was measured by immunoturbidimetric
assay using Olympus AU 640, and plasma and urinary cre-
atinine were measured by enzymatic colorimetric assay
using Olympus AU 640 (Olympus corporation, Tokyo,
Japan). Assay variation was checked daily with an internal
quality assessment scheme, and the coefficient of variation
for each test was below 5%.
Definitions of chronic diseases and risk factors
We defined a participant as having T2DM if he or she
had fasting blood glucose ≥ 7.0 mmol/L or hemoglobin
A1c ≥ 6.5% or medication use for self-reported diabetes.
We defined metabolic syndrome according to International
Diabetes Federation criteria [12] as centripetal obesity
(waist circumference ≥ 90 cm for men and ≥ 80 cm for
women) plus any two of the followings: (1) triglycer-
ides > 1.7 mmol/L or treatment for elevated trigly-
cerides, (2) HDL cholesterol < 1.03 mmol/L in men or
< 1.29 mmol/L in women, or treatment for low HDL,
(3) systolic blood pressure > 130 mmHg, diastolic blood
pressure > 85 mmHg, or treatment for hypertension, and
(4) fasting plasma glucose > 5.6 mmol/L. We defined a
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criteria for T2DM or metabolic syndrome. We used the
following categories for Quételet’s (body mass) index
(BMI): < 25 (lean or normal), 25 to < 30 (overweight), and
≥ 30 kg/m2 (obese). We captured leisure time physical ac-
tivity by the following question: ‘How often do you walk
outside the home for more than 10 minutes without stop-
ping?’ We categorized the responses as ‘Rarely,’ ‘Weekly’,
or ‘Daily.’
We defined a participant as having cardiovascular dis-
ease if he or she reported using medications for blood
pressure or heart disease, or had systolic blood pressure
≥ 140 mmHg and diastolic blood pressure ≥ 90 mmHg.Table 1 Characteristics of participants with available
serum creatinine determinations (n = 357)
Men mean ± SD Women mean ± SDDefinition of CKD
We used the Chronic Kidney Disease Epidemiology Col-
laboration (CKD-EPI) equation to estimate glomerular
filtration rate (eGFR), and the National Kidney Founda-
tion Kidney Disease Outcomes Quality Initiative (NKF/
KDOQI) guidelines to define and stage CKD [11]. We
used a sex- specific cut off for albuminuria: ≥ 1.9 mg/
mmol (17 mg/g) creatinine for men, and ≥ 2.8 mg/mmol
(25 mg/g) creatinine for women. Thus we defined a par-
ticipant as having CKD if he or she had eGFR below
60 ml/min/1.73 m2 or had albuminuria. We also present
prevalence results for albuminuria and CKD using the
≥ 3.4 mg/mmol (30 mg/g) creatinine cutoff.or N (%) or N (%)
Demographics
Age (in years) 49.4 ± 12.1 49.6 ± 13.4
Married* 170 (93) 125 (71)
High school education
or more*
96 (53) 53 (30)
Employed* 139 (76) 125 (71)
Wealth index > 3† 33 (18) 34 (19)
Residence in Dhaka (in years)* 30.0 ± 16.2 33.8 ± 15.1
Clinical characteristics
BMI (kg/m2) categories
< 25 92 40
25 to < 30 82 71
≥ 30 51 21
Smoker (current or past)* 107 (59) 5 (3)
Smokeless tobacco user* 30 (17) 45 (26)
Self-reported hypertension* 57 (31) 76 (43)
Measured systolic blood
pressure
118.4 ± 15.7 117.8 ± 16.6
Measured diastolic blood
pressure
74.6 ± 11.2 74.5 ± 13.3
*represents significant difference at the p < 0.05 level. †A wealth index above
3 indicates owning 3 or more of: apartment/house, car, power source, or air
conditioner. Abbreviations: BMI-Quételet’s (body mass) index,
SD-standard deviation.Statistical analyses
We present continuous data as mean (± standard devi-
ation) and categorical data as proportions, with compari-
sons via Student’s t-test or Pearson’s χ2 test, as appropriate.
We stratified by sex and performed logistic regression to
test the associations among potential covariates including
education, wealth status, physical activity, tobacco use,
measures of body size (BMI, waist circumference, and
waist-to-hip ratio), and presence of insulin resistance or
cardiovascular disease. We used generalized linear models
to evaluate the association between CKD and the Physical
and Mental Health Composite t-scores on the SF-12. We
used the New England Medical Center (NEMC) guidelines
to score the SF-12 [13]. The primary analysis evaluated
these associations using NKF/KDOQI stages of CKD, cal-
culated based on eGFR and/or albuminuria. In multivari-
able analyses, we adjusted for the residual effects of age
and sex, as well as for insulin resistance. Since age and sex
are embedded in the eGFR calculation, we performed com-
panion analyses in which we used the reciprocal of serum
creatinine as a marker for kidney function. We considered
inference tests as significant if the two-tailed p-value was
<0.05. We conducted all analyses using SAS, v9.3 (SAS
Institute Inc., Cary, NC).Results
A total of 357 (89%) participants provided serum samples
and comprise the analytic cohort; 182 (51%) were men
and 175 (49%) were women. Spot urine albumin and cre-
atinine were assessed among 341 (96%) participants. As
reported previously, men were more likely to be married,
employed, and educated at the high school level (Table 1)
compared with women. Men also had lower mean BMI,
and were more likely to use cigarettes, whereas women
more often consumed smokeless tobacco. Two hundred
and twelve (59%) participants had features of insulin
resistance, 138 (65%) of whom had T2DM.
CKD prevalence
Ninety-four (26%) participants met the definition of CKD
(Figure 1a and b), 45 men and 49 women. A majority (n =
58 (62%)) had stage one or two CKD (i.e., albuminuria
only). Among the 36 participants with stage three or more
advanced CKD, 21 (58%) had associated albuminuria.
Overall, there were 79 (22%) participants with albumin-
uria, 65 (83%) of whom had microalbuminuria (Figure 2).
Using an albuminuria cutoff of ≥ 3.4 mg/mmol creatinine,
56 and 72 (20%) participants were classified as having











































Figure 1 Stages of CKD with details on albuminuria for stage
three CKD. a. Stages of CKD. Overall 94 (27%) of participants had
CKD. Stage one or two CKD (albuminuria with eGFR > 90 or
between 60–90 ml/min/1.73 m2) was present in 58 (62%). Stage five
CKD was present in 4 (4%). Abbreviations: CKD-Chronic kidney disease,
eGFR-estimated glomerular filtration rate. b. Characterizing stage three
CKD. Among participants with stage three CKD (n = 26, 28%), 6 (23%)
had an isolated reduction in eGFR between 45–59 ml/min/1.73 m2;
all others had either stage 3b CKD or accompanying albuminuria.
Abbreviations: CKD-chronic kidney disease; eGFR-estimated glomerular
filtration rate.
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On unadjusted analyses, education level was not associated
with the presence of CKD among men, although among
women, those who had received fewer than 5 years of edu-
cation experienced higher odds of CKD compared with
women educated at the University level or beyond (Odds
ratio [OR] 3.6, 95% Confidence Interval [CI] 1.4 to 9.4).
Wealth status was not associated with CKD among women
or men. Since smokers in our sample were predominantly
(96%) men, we tested the association between smoking and
CKD among men only and found no association. Use of
smokeless (chewable) tobacco was associated with higher
odds of CKD among women (OR 2.8, 95% CI 1.4 to 5.7).
Larger waist circumference and waist-to-hip ratio (using
International Diabetes Foundation criteria) [12], BMI, and
leisure-time physical activity were not significantly associ-
ated with CKD.CKD and insulin resistance
A majority of participants with CKD also had features of
insulin resistance (Figure 3). The unadjusted odds of
CKD among participants with insulin resistance were 3.6
fold higher (95% CI 2.1 to 6.4) than among participants
without insulin resistance. Upon stratification by sex, the
odds of CKD among men with insulin resistance were
3.1 (95% CI 1.5 to 6.4) and among women were 4.7 (95%
CI 1.9 to 11.9). Cardiovascular disease was also evident
in more than two-thirds (n = 64, 68%) of participants
with CKD. The measured average blood pressure of a
participant with CKD was 125/78 mmHg, approxi-
mately 10/5 points higher than in participants without
CKD (p <0.001 and 0.005, for systolic and diastolic
pressure, respectively).CKD and HRQoL
Mean t-scores on the SF-12 NEMC Physical Health
Composite t-Score (PCS) were lower among participants
with CKD (Table 2). There was no significant difference
in mean t-scores on the SF-12 Mental Health Composite
Score (MCS), although the mean MCS for participants
with stage five CKD was significantly lower than for all
other stages. Multivariable analyses adjusting for the
residual effects of age and gender as well as for insulin
resistance showed that mean scores on PCS were signi-
ficantly lower among participants with stage three or
more advanced CKD.
On companion analyses using the reciprocal of serum
creatinine as a main exposure of interest (as opposed to
eGFR), we found that the PCS was inversely correlated
with serum creatinine and age, and was lower among
women compared with men.
Discussion
Among randomly sampled adults living in a middle-
income neighborhood of Bangladesh, approximately one
in five were found to have CKD. Nearly four of five par-
ticipants with CKD had features of insulin resistance,
which was the predominant risk factor linked with CKD
in our study. In contrast to data from the U.S. and other
countries where stage three CKD predominates [14-16],
we found that stage one or two CKD (albuminuria only)
was most common. The high prevalence of insulin re-
sistance and associated albuminuria among our partici-
pants with CKD implies that they are at high risk for
progression of CKD and for experiencing a cardiovascu-
lar event.
No prior data exist on prevalence of CKD in Bangladesh.
Two studies from New Delhi, India have used variable def-
initions of CKD. A study of 4,712 adults living in South
Delhi found that 0.8% had serum creatinine above 159
umol/L (1.8 mg/dL) [5]; the comparable percentage in our
Figure 2 Distribution of microalbuminuria in men and women. Microalbuminuria was defined as 1.9-34 mg/mmol (17 – 300 mg/g)
creatinine for men and (2.8-34 mg/mmol (25 – 300 mg/g) creatinine for women. There were a total of 79 (22%) cases of albuminuria, 65 (83%) of
which were in the microalbuminuria range.







No chronic kidney disease (ref) 40.2 ± 0.6 41.1 ± 0.7
Chronic kidney disease (n = 94)
Stage 1 or 2 (n = 58) 38.6 ± 1.3 43.0 ± 1.2
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Delhi reported a prevalence of reduced eGFR (below
60 ml/min/1.73 m2) equal to 4% [6]; the comparable per-
centage in our study was 10%. The Thai-Global Screening
and Early Evaluation of Kidney Disease (SEEK) study sam-
pled 3,459 from 10 provinces. Both albuminuria and
serum creatinine were evaluated and the standard NKF/
KDOQI definition was applied; 17% of surveyed partici-
pants met criteria for CKD [17]. As reference, the most
recent estimates of CKD prevalence from Norway [18],
Spain [15], U.S. [14], and Japan [16] are between 10 and
13% of the adult population.
We hypothesize three reasons for the higher prevalence
of CKD noted in our study. First, we surveyed adults over
30 years old, whereas Thai-SEEK and NHANES enrolledFigure 3 Overlap between insulin resistance and chronic
kidney disease. Of the 94 participants with CKD, 75 (79%) were
among participants with insulin resistance, defined as metabolic
syndrome or T2DM. Of these, 59 (63%) had T2DM. Abbreviations:
CKD—chronic kidney disease, T2DM-type two diabetes mellitus.adults over 18 and 20 years old, respectively. Second, by
surveying a well-established neighborhood of a major
urban hub, we are sampling from a population at higher
risk, not representative of the risk experienced by people
living in rural areas or poorer persons. Migrating to anStage 3 (n = 26) 34.9 ± 2.0 45.6 ± 1.7
Stage 4 (n = 6) 29.2 ± 2.0 32.9 ± 6.2
Stage 5 (n = 4) 27.6 ± 2.2 23.3 ± 4.2
Adjusted model*
No chronic kidney disease (ref)
Chronic kidney disease 39.8 ± 0.5 40.9 ± 0.7
Stage 1 or 2
Stage 3 39.1 ± 1.1 43.3 ± 1.4
Stage 4 36.6 ± 1.8 Up
Stage 5 32.2 ± 3.5 34.6 ± 4.6
Values in bold are significantly different from the referent category.
*Adjusted for insulin resistance, and residual effects of age and gender. Stages
are based on the National Kidney Foundation/Kidney Disease Outcomes
Quality Initiative definition of chronic kidney disease. Abbreviations: PCS: New
England Medical Center Physical Health Score, MCS: Mental Health Score, SE:
standard error.
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increase in odds of a sedentary lifestyle, three-fold increase
in odds of obesity, and two-fold increase in odds of T2DM
among men working in factories in India, compared with
their rural counterparts [3]. In low-income countries, the
prevalence of obesity increases with increasing wealth,
although this trend may soon arrest or reverse as prices of
fruits and vegetables climb while processed foods become
cheaper and more easily accessible [19].
A majority of participants who were identified as having
CKD had stage one or two CKD (i.e., albuminuria only).
As we did not repeat assessment of albuminuria, we do
not have population-specific data on persistent albumin-
uria. However extrapolating data from NHANES on spot
versus persistent albuminuria, 51% of participants with
microalbuminuria and stage one CKD and 75% of partici-
pants with microalbuminuria and stage two CKD would
be estimated to have persistent microalbuminuria, yielding
an adjusted (approximate) CKD prevalence equal to 19%,
rather than 26%. Thus, the prevalence of CKD in the
urban Bangladeshi population would still be higher than
that in the U.S., Europe, and Japan. Strikingly, we identi-
fied four persons (1%) with stage five CKD (eGFR below
15 ml/min/1.73 m2). If we extrapolate only to the >30 year
old population of Mohammedpur, a stage five CKD preva-
lence of 1% would imply that roughly 1,800 persons would
be at risk for imminent kidney failure in a district that rep-
resents 0.3% of the Bangladeshi population. Even these
1,800 persons represent an immense burden in a country
where kidney transplants are performed in only one and
dialysis in just four of 13 government hospitals [20].
Aside from the need for transplantation or dialysis,
persons with CKD (especially those with albuminuria)
experience an increased risk for cardiovascular disease
and mortality. Microalbuminuria, found in 70% of our
participants with CKD, has been linked to a 30 to 80%
increase in the risk for all-cause and cardiovascular mor-
tality; overt proteinuria, found in 15% of our participants
with CKD, can double or triple these risks [21]. The ma-
jority of our participants with CKD also had T2DM,
which increases risk for all-cause and cardiovascular
mortality 20 to 90%, relative to persons with CKD who
do not have T2DM [1].
In Bangladesh, care for chronic illnesses is not yet in
line with the care for infectious diseases; much of the
public sector health budget is devoted to treating epi-
sodic illnesses such as diarrhea or respiratory illness. No
national guidelines exist for primary health care screening
for chronic illnesses such as CKD. Even among patients
identified to have a chronic illness, cost of treatment is
a major burden: while the government subsidizes some
of the care (e.g., the doctor’s visit) in the public sector,
patients may still pay for other aspects (e.g., medica-
tions). Some subsidies are available from social welfareorganizations. Those who can afford it do seek private care,
and a negligible percent goes abroad for better treatment.
We also found that moderate to advanced CKD was as-
sociated with a decrement in self-reported physical health.
While few studies have explored HRQoL in patients with
non-dialysis requiring CKD, the associated decrement in
self-reported physical health seen among participants with
moderate to advanced CKD in this study is considered to
be clinically meaningful [22]. Thus, if the burden of CKD
is not lessened in the coming decades, we can anticipate
higher rates of cardiovascular disease, frailty, and debility
in the urban Bangladeshi population, even in late middle
and early older age.
Our study has several strengths. We adopted a random
sampling procedure in this community-based survey.
Trained and experienced nurses and research assistants
used standardized protocols for physical measurements.
Anticipating low rates of awareness of chronic diseases,
we employed laboratory measurement to diagnose T2DM,
metabolic syndrome, and CKD. Ours is one of few studies
in the region to include an assessment of albuminuria and
HRQoL.
However, given our modest sample size and that our
survey was limited to a particular urban neighborhood,
we cannot extrapolate our findings to all of Bangladesh.
Our modest sample size also limited our assessment of
the correlates of CKD. Ideally, repeat measures of serum
creatinine and urinary albumin excretion might allow us
to be more precise in our prevalence estimates.Conclusions
Our study points to an alarmingly high rate of CKD—
roughly one in five—among urban middle-income Bangla-
deshis. The kidney disease we detected will pose a signifi-
cant clinical burden to this resource-poor setting with
limited healthcare infrastructure and very limited capacity
to manage advanced and end-stage disease. Additional
studies are required to define CKD prevalence, incidence
rates, and region- and population-specific risk factors in
low- and middle-income countries around the globe, as
well as an urgent need to design low-cost programs to de-
tect and manage CKD in Bangladesh and other countries
in South Asia.Abbreviations
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